<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">313172</article-id><article-id pub-id-type="doi">10.18565/pharmateca.2021.6.100-107</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Vitamin and mineral complex for pregnant women: modern formula</article-title><trans-title-group xml:lang="ru"><trans-title>Витаминно-минеральный комплекс для беременных: современная формула</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dikke</surname><given-names>G. B</given-names></name><name xml:lang="ru"><surname>Дикке</surname><given-names>Г. Б</given-names></name></name-alternatives><bio xml:lang="en"><p>Dr. Sci. (Med.), Associate Professor, Professor at the Department of Obstetrics and Gynecology with a Course in Reproductive Medicine</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, профессор кафедры акушерства и гинекологии с курсом репродуктивной медицины</p></bio><email>galadikke@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Academy of Medical Education n.a F.I. Inozemtsev</institution></aff><aff><institution xml:lang="ru">Академия медицинского образования им. Ф.И. Иноземцева</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2021</year></pub-date><volume>28</volume><issue>6</issue><issue-title xml:lang="en">VOL 28, NO6 (2021)</issue-title><issue-title xml:lang="ru">ТОМ 28, №6 (2021)</issue-title><fpage>100</fpage><lpage>107</lpage><history><date date-type="received" iso-8601-date="2023-03-03"><day>03</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО «Бионика Медиа»</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/313172">https://journals.eco-vector.com/2073-4034/article/view/313172</self-uri><abstract xml:lang="en"><p>Taking vitamin-mineral complexes (VMCs) during pregravid preparation and pregnancy improves maternal and fetal outcomes. The use of VMCs containing essential vitamins and minerals with proven efficacy in reducing the incidence of pregnancy complications is recommended, while there is a need to limit the intake of excess amount of micronutrients with unproven efficacy. Currently, both new VMCs and already well-known brands with a new composition are being produced, which reflects the search for evidence-based components and their doses. The originality of the composition of the VMC Femibion-I, -II is attributable to thee content of folic acid and metafoline in a 1:1 ratio and omega-3 docosahexaenoic acid in a separate capsule (in composition II). The addition of chelated iron in the form of bisglycinate allows avoiding side effects and achieving better tolerability, while zinc contributes to additional stimulation of hematopoi-esis. Choline is a unique micronutrient (in composition I), has a positive effect on the development of the fetus and its nervous system, and Femibion is so far the only brand in Russia that contains choline. Conclusion. Femibion-I, -II (new formula) contains essential vitamins and minerals in optimal doses proved by the results of modern research. The introduction of additional micronutrients is justified due to the high prevalence of their deficiency among pregnant women. Femibion-I differs from other VMCs due to content of choline, a unique vitamin-like substance, which has a positive effect on fetal development.</p></abstract><trans-abstract xml:lang="ru"><p>Прием витаминно-минеральных комплексов (ВМК) в период прегравидарной подготовки и во время беременности способствует улучшению исходов для матери и плода. Рекомендуется использование ВМК, содержащих необходимые витамины и минералы с доказанной эффективностью в отношении снижения частоты осложнений беременности, при этом существует необходимость в ограничении приема содержащих избыточное количество микронутриентов с недоказанной эффективностью. В настоящее время выпускают как новые ВМК, так и уже известные бренды с новым составом, что отражает поиск научно обоснованных компонентов и их доз. Оригинальность композиции ВМК Фемибион-I, -II* обусловлена содержанием фолиевой кислоты и метафолина в соотношении 1:1 и Омега-3 докозагексаеновой кислоты в отдельной капсуле (в композиции II). Добавка хелатного железа в форме бисглицината позволяет избегать побочных эффектов и добиваться лучшей переносимости, а цинк способствует дополнительному стимулированию кроветворения. Холин - уникальный микронутриент (в композиции I), обладает положительным действием на развитие плода и его нервной системы, а Фемибион - пока единственный бренд в России, в состав которого входит холин. Заключение. Фемибион-I, -II (новая формула) содержат необходимые витамины и минералы в оптимальных дозах, обоснованных результатами современных научных исследований. Введение дополнительных микронутриентов оправданно ввиду высокой распространенности недостаточности их среди беременных женщин. Холин, являющийся уникальным витаминоподобным веществом, отличает Фемибион-I от других ВМК и оказывает положительное действие на развитие плода.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>vitamins</kwd><kwd>minerals</kwd><kwd>nutritional supplements</kwd><kwd>folic acid</kwd><kwd>metafoline</kwd><kwd>docosahexaenoic acid</kwd><kwd>choline</kwd><kwd>Femibion</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>витамины</kwd><kwd>минералы</kwd><kwd>пищевые добавки</kwd><kwd>фолиевая кислота</kwd><kwd>метафолин</kwd><kwd>докозагексаеновая кислота</kwd><kwd>холин</kwd><kwd>Фемибион</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gernand A.D., Schulze K.J., Stewart C.P., et al. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol. 2016;12(5):274-89. Doi:10.1038/ nrendo.2016.37.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Keats E.C., Haider B.A., Tam E., Bhutta I.A. Multiplemicronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;3:CD004905. Doi: 10.1002/14651858. CD004905.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience. Geneva, Switzerland: World Health Organization, 2016. 175 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: Multiple micronutrient supplements during pregnancy. Geneva: World Health Organization, 2020. 172 p.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>ACOG. Nutrition During Pregnancy. FAQ001, April 2015. 3 р.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wilson R.L., Gummow J.A., McAninch D., et al. Micronutrient supplementation in pregnancy. J. Pharm Pract Res. 2018;48:186-92. Doi: 10.1002/jppr.1438.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>РОАГ Нормальная беременность. Клинические рекомендации (протокол лечения). М., 2019. 88 с.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mousa A., Naqash A., Lim S. Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence. Nutr. 2019;11(2):443. Doi: 10.3390/nu11020443.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bakouei F, Delavar M.A., Mashayekh-Amiri S., et al. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and metaanalysis. Taiwan J Obstet Gynecol. 2020;59(1):8 15. Doi: 10.1016/j.tjog.2019.11.002</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Brown B, Wright C. Safety and efficacy of supplements in pregnancy. Nutr Rev 2020;78( 10):813-26. Doi:10.1093/nutrit/ nuz101</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Good clinical practice advice: Micronutrients in the periconceptional period and pregnancy. FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine. Obstet Gynecol. 2019;44(3):317-21. Doi: 10.1002/ijgo.12739</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>WHO. Periconceptional folic acid supplementation to prevent neural tube defects. URL: https://www. who. ini</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization, 2012. URL: http://www.who.int/ nutrition</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>WHO, UNICEF. Reaching optimal iodine nutrition in pregnant and lactating women and young children: a joint statement by WHO and UNICEF. Geneva, World Health Organization, 2007.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Wilson R.D. Wilson R.D., Audibert F, Brock J.A., et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can. 2015;37(6):534-52. Doi: 10.1016/s1701-2163(15)30230-9.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Interim Summary of Conclusions and Dietary Recommendations on Total Fat &amp; Fatty Acids. From the Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition, 10-14. November, 2008, WHO, Geneva.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Oh C., Keats E.C., Bhutta Z.A. Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Nutr. 2020;12(2):491. Doi: 10.3390/nu12020491.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Willems FF, Boers G.H., Blom H.J., et al. Pharmacokinetic study on the utilisation of 5-methyltetra-hydrofolate and folic acid in patients with coronaryarterydisease. Br JPharmacol. 2004;141(5):825 30. Doi: 10.1038/sj.bjp.0705446</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>De-Regil L.M., Peha-Rosas J.P., Fernandez-Gaxiola A.C., Rayco-Solon P Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;(12):CD007950. Doi: 10.1002/14651858.CD007950.pub3.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Li B., Zhang X., Peng X., et al. Folic Acid and Risk of Preterm Birth: A Meta-Analysis. Front Neurosci. 2019;13:1284. Doi: 10.3389/ fnins.2019.01284.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Li N., Li Z., Ye R., et al. Impact of Periconceptional Folic Acid Supplementation on Low Birth Weight and Small-for-Gestational-Age Infants in China: A Large Prospective Cohort Study. J Pediatr. 2017;187:105-10. Doi: 10.1016/j. jpeds.2017.04.060.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Liu C., Liu C., Wang Q., Zhang Z. Supplementation of folic acid in pregnancy and the risk of preeclampsia and gestational hypertension: a meta-analysis. Arch Gynecol Obstet. 2018;298(4):697-704. Doi:10.1007/s00404-018-4823-4.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gaskins A.J., Rich-Edwards J.W., Hauser R., et al. Maternal prepregnancy folate intake and risk of spontaneous abortion and stillbirth. Obstet Gynecol. 2014;124(1):23-31. Doi: 10.1097/ AOG.0000000000000343.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Greenberg J.A., Bell S.J. Multivitamin Supplementation During Pregnancy: Emphasis on Folic Acid and l-Methylfolate. Rev Obstet Gynecol. 2011;4(3-4):126-27.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Obeid R., Holzgreve W., Pietrzik K. Is 5-methyltetrahydrofolate an alternative to folic acid for the prevention of neural tube defects? J Perinat Med. 2013;41(5):469-83. Doi: 10.1515/ jpm-2012-0256.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Greenberg J.A., Bell S.J., Guan Y, Yu YH. Folic Acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol. 2011;4(2):52-9.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Лиманова О.А. О новых тенденциях в нутрициальной поддержке беременности. Акушерство и гинекология. 2018;1:21-8. Doi: 10.18565/aig.2018.1.21-28.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zempleni J., Mock D.M. Marginal biotin deficiency is teratogenic. Proc Soc Exp Biol Med. 2000;223(1):14-21. Doi: 10.1046/j.1525-1373.2000.22303.x.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Pasten-Hidalgo K., Riveron-Negrete L., Sicilia-Argumedo G., et al. Dietary Biotin Supplementation Impairs Testis Morphology and Sperm Quality. J Med Food. 2019;29. Doi:10.1089/jmf.2019.0137.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>RCOG. Nutrition in Pregnancy. Scientific Impact Paper No. 18. Revised September 2010. URL: https://www.rcog.org.uk.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>RANZCOG. Vitamin and Mineral Supplementation and Pregnancy. May 2015. 14 р. URL: https:// ranzcog.edu.au</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Coletta J.M., Bell S.J., Roman A.S. Omega-3 Fatty acids and pregnancy. Rev Obstet. Gynecol. 2010;3(4):163-71.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Middleton P, Gomersall J.C., Gould J.F. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018;(11):CD003402. Doi: 10.1002/14651858.CD003402.pub3.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Vollet K., Ghassabian A., Sundaram R., et al. Prenatal fish oil supplementation and early childhood development in the Upstate KIDS Study. J Dev Orig Health Dis. 2017;8(4):465-73. Doi: 10.1017/S2040174417000253.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Reference Guide: Changing the Daily Value of Nutrients. FDA, 2020. URL:https://www.fda.gov/ media/135301/download</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Громова О.А., Торшин И.Ю., Зайчик Б.Ц., Ружицкий А.О. Комплексное исследование количества и видов насыщенных и полиненасыщенных жирных кислот в составе препаратов. Медицинский алфавит. 2019;4(33):15 24</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Методические рекомендации. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора, 2009. 36 с</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Andersson M., de Benoist B., Delange F., et al. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. WHO Secretariat on behalf of the participants to the Consultation. Health Nutr. 2007;10(12A):1606 11. Doi: 10.1017/S1368980007361004</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>WHO. The global prevalence of anaemia in 2011. Geneva: World Health Organization, 2015. 48 р. URL: https://apps.who.int</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>РОАГ Федеральные клинические рекомендации. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц. М., 2013. 26 с.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>ВОЗ. Ежедневные добавки железа и фолиевой кислоты во время беременности. ВОЗ, 2019. [WHO. Daily iron and folate supplementation during pregnancy. WHO, 2019. (in Russ.)]. URL: https://www.who.ini</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Дикке Г.Б. Анемия беременных - проблема общественного здравоохранения. Фарматека. 2017;12:8-13</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Milman N, J0nsson L., Dyre P, et al. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014;42(2):197-206. Doi: 10.1515/jpm-2013-0153.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Youssef A.M., Shata A.F, Kamal H.M., et al. A Comparative Study of Efficacy, Tolerability, and Compliance of Oral iron Preparations for iron Deficiency Anemia in Pregnant Women. Am. J Med Sci. 2014;4:244-49. Doi:10.5923/j. ajmms.20140406.09.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Ferrous bisglycinate as a source of iron for use in the manufacturing of foods and in food supplements. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and materials in Contact with Food. EFSA J. 2006:299:1-17. Doi: 10.2903/j.efsa.2006.299.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Таюпова И.М. К вопросу рационального питания, коррекции микронутриентного статуса, профилактики и лечения дефицита железа у беременных. Вопросы питания. 2015;2:25-33.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Дикке ГБ., Стуклов Н.И. Латентный дефицит железа и железодефицитная анемия у беременных. Алгоритмы диагностики и лечения. Фарматека. 2021;28(6):19-24. Doi: 10.18565/ pharmateca.2021.6.19-24.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Jeppsen R.B., Borzelleca J.F. Safety evaluation of ferrous bisg1ycinate che1ate. Food Chem Tox. 1999;37:723-31. Doi: 10.1016/s0278-6915(99)00052-6.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Carducci B., Keats E.C., Bhutta I.A. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev. 2021:CD000230. Doi: 10.1002/14651858. CD000230.pub.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Серов В.Н., Блинов Д.В., Зимовина У. В., Джобава Э.М. Результаты исследования распространенно -сти дефицита магния у беременных. Акушерство и гинекология. 2014;6:33-40.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Спасов А.А. и др. Сравнительная фармакологическая активность органических и неорганических солей магния в условиях системной алиментарной гипомагнезиемии. Вестник Российской академии медицинских наук. 2010;2:29-37.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Makrides M., Crosby D.D., Bain E., Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014;(4):CD000937.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Rylander R. Treatment with Magnesium in Pregnancy. AiMS Public Health. 2015;2(4):804-9.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Барсук А.Л. Биодоступность оксида и других соединений магния при пероральном приеме (обзор). РМЖ. 2014;10:744-8.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Scientific Opinion on Dietary Reference Values for magnesium. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). EFSA J. 2015;13(7):4186. Doi: 10.2903/j. efsa.2015.4186</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Mistry H.D., Kurlak L.O., Young S.D., et al. Maternal selenium, copper and zinc concentrations in pregnancy associated with small-for-gestational-age infants. Matern Child Nutr. 2014;10(3):327 34. Doi:10.1111/j.1740-8709.2012.00430.x</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Johnson E.J. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev. 2014;72:605-12. Doi: 10.1111/ nure.12133</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Berg S. AMA backs global health experts in calling infertility a disease. Prenatal supplementation. JUN 13, 2017. American Medical Association (AMA) 2017 Annual Meeting, June 10-14, 2017, Chicago, illinois</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>EFSA. Dietary Reference Values for Choline. EFSA J. 2016;14(8):4484-554. Doi: 10.2903/j. efsa.2016.4484.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Schwarzenberg S.J., Georgieff M.K.; committee on nutrition. Advocacy for improving Nutrition in the First 1000 Days to Support Childhood Development and Adult Health. Pediatr. 2018;141( 2):e20173716. Doi: 10.1542/ peds.2017-3716.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Caudill M.A. Pre- and postnatal health: evidence of increased choline needs. J. Am Diet Assoc. 2010;110(8):1198-206. Doi: 10.1016/j. jada.2010.05.009.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Jiang X., Yan J., West A.A., Pet al. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J. 2012;26(8):3563-74. Doi: 10.1096/fj.12-207894.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>McCorry L.K. Physiology of the autonomic nervous system. Am J. Pharm Educ. 2007;71(4):78. Doi: 10.5688/aj710478.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>National institutes of Health. Choline. Fact Sheet for Health Professionals. Updated: March 29, 2021. URL: https://ods.od.nih.gov</mixed-citation></ref></ref-list></back></article>
